Edition:
United States

Antisense Therapeutics Ltd (ANP.AX)

ANP.AX on Australia Stock Exchange

0.04AUD
20 Jan 2017
Change (% chg)

$-0.00 (-2.38%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
50,000
Avg. Vol
152,091
52-wk High
$0.06
52-wk Low
$0.03

ANP.AX

Chart for ANP.AX

About

Antisense Therapeutics Limited (ANP) is an Australia-based pharmaceutical drug discovery and development company. The Company is engaged in the research and development of antisense pharmaceuticals. The Company's product candidate, ATL1103, is an antisense drug designed to block growth hormone receptor (GHr) expression thereby... (more)
No analyst recommendations are available for ANP.AX.

Overall

Beta: 1.51
Market Cap(Mil.): $7.41
Shares Outstanding(Mil.): 176.51
Dividend: --
Yield (%): --

Financials

  ANP.AX Industry Sector
P/E (TTM): -- 44.51 30.50
EPS (TTM): -0.01 -- --
ROI: -43.10 -1.38 14.85
ROE: -43.10 -1.00 16.27

Earnings vs. Estimates

No consensus analysis data available.